跳至主要内容
临床试验/TCTR20220201001
TCTR20220201001尚未招募4 期

Efficacy of standard triple therapy with statin compared with standard triple therapy in Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial

The Gastroenterological Association of Thailand (GAT)0 个研究点目标入组 234 人开始时间: 2022年2月1日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
入组人数
234

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1.H.pylori infection patients by use of Invasive test: EGD with CLO test/Biopsy or Non-invasive test: UBT, stool Antigen
  • 2.Aged more than 18 years
  • 3.Can read and write of Thai language.

排除标准

  • 1.Previous treatment with statin, 2.Presence of severe comorbidities, 3. Gastrointestinal malignancy or previous gastric surgery, 4.Prior H. pylori eradication therapy, 5.History of antibiotics, PPI, histamine H2 receptor blockers, nonsteroidal or anti-inflammatory drugs, bismuth salts within the last month, 6. Allergy of any of the antibiotics used, statin in the study,7. Active upper gastrointestinal bleeding, 8.Pregnant or breastfeeding women, 9. Ongoing use of drug that may interaction with atorvastatin such as cyclosporine, protease inhibitors, itraconazole, 10. Active hepatitis or rhabdomyolysis

研究者

相似试验

Efficacy of standard triple therapy with statin... | 临床试验